These results indicate that elevated VEGF-C levels contribute to metabolic deterioration and the development of insulin resistance, and that blockade of VEGF-C in obesity represents a suitable approach to alleviate the development of insulin resistance. This evidence concerns the gene VEGFC and obesity due to melanocortin 4 receptor deficiency.